SCHEMBL25569690

SCHEMBL25569690

CN(P)c1ccc(C(N)=O)cn1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NNMT P40261 4/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HCAR3 P49019 2/20 0.44
KDM4E B2RXH2 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GRM5 P41594 1/20 0.41
F7 P08709 1/20 0.39
F3 P13726 1/20 0.39
SARM1 Q6SZW1 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
SIRT6 Q8N6T7 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
SIRT3 Q9NTG7 1/20 0.39
SIRT5 Q9NXA8 1/20 0.39
SIRT4 Q9Y6E7 1/20 0.39
HPGDS O60760 1/20 0.39
MKNK1 Q9BUB5 2/20 0.39
MKNK2 Q9HBH9 2/20 0.39
EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976946 0.85 NNMT (0.55) NNMTSMN1; SMN2HCAR3KDM4EL3MBTL1
Hydrochloric Acid SCHEMBL2674517 0.84 NNMT (0.53) NNMTSMN1; SMN2HCAR3KDM4EL3MBTL1
Hydrochloric Acid SCHEMBL5009849 0.84 NNMT (0.53) NNMTSMN1; SMN2HCAR3KDM4EL3MBTL1
SCHEMBL3464465 0.81 NNMT (0.50) NNMTSMN1; SMN2HCAR3KDM4EL3MBTL1
SCHEMBL3132351 0.78 NNMT (0.47) NNMTSMN1; SMN2HCAR3KDM4EL3MBTL1
SCHEMBL18433935 0.77 HCAR3 (0.55) NNMTSMN1; SMN2HCAR3KDM4EL3MBTL1
SCHEMBL3465544 0.77 HCAR3 (0.57) NNMTSMN1; SMN2HCAR3KDM4EL3MBTL1
SCHEMBL14852700 0.77 HCAR3 (0.75) NNMTSMN1; SMN2HCAR3KDM4EL3MBTL1
Hydrochloric Acid SCHEMBL5013471 0.76 HCAR3 (0.54) NNMTSMN1; SMN2HCAR3KDM4EL3MBTL1
SCHEMBL25569692 0.76 NNMT (0.53) NNMTSMN1; SMN2HCAR3SIRT3MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159470-A1 INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE, COMPOSITIONS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159470-A1 INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE, COMPOSITIONS AND USES THEREOF NNMT, NNT, NAMPT NNMT 1/4885SMN1; SMN2 1143/4885HCAR3 3155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.